Literature DB >> 8153657

Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate.

R Rosell1, J Gómez-Codina, A Anton, J J Sánchez, C Vadell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8153657

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  1 in total

1.  Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.

Authors:  C Huisman; B Biesma; P E Postmus; G Giaccone; F M Schramel; E F Smit
Journal:  Br J Cancer       Date:  2001-11-16       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.